About
Technology
Issues
FAQ
Links
Official Page
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.